DENSPM is a potent anticancer agent; it activates polyamine catabolism as a spermine analog; induces mitochondrial release of cytochrome c, leading to caspase-3 activation; and kills glioblastoma multiforme (GBM) cells by inducing spermidine/spermine N1-acetyltransferase (SSAT) and generating hydrogen peroxide.